Active Pharmaceutical Ingredients
Duloxetine Pellets are designed to deliver Duloxetine Hydrochloride, a serotonin-norepinephrine reuptake inhibitor (SNRI). They are generally formulated as enteric-coated or sustained/modified-release pellets to ensure stability in gastric conditions and control release in the intestinal tract.
| Component | Function |
|---|---|
| Duloxetine Hydrochloride | Active Pharmaceutical Ingredient (API) |
| Sugar Spheres / MCC Spheres | Inert core or starter pellets |
| Hydroxypropyl Methylcellulose (HPMC) | Binder / Film former during layering |
| Talc / Colloidal Silicon Dioxide | Anti-adherent / Glidant |
| Eudragit L30D-55 or Eudragit S100 | Enteric coating polymer – pH dependent release (intestinal) |
| Triethyl Citrate / PEG 6000 | Plasticizer (for polymer coating) |
| Purified Water | Solvent (removed after processing) |
Outsourcing pellets through a trusted partner like Salius Pharma can be a strategic decision to save both time and resources, without compromising on quality or compliance. Instead, partnering with Salius Pharma—a leading distributor aligned with USFDA-approved and WHO-GMP-certified manufacturers in India—allows you to leverage high-quality products, seamless logistics, and professional support under one roof.
We ensure prompt and reliable shipping worldwide. Delivery times may vary depending on destination, order volume, and regulatory requirements.
Looking to source Duloxetine Pellets or other high-quality pharmaceutical pellet formulations?
Whether you need Active Pharmaceutical Ingredients (APIs), excipients, or regulatory support, our team is ready to provide reliable, compliant, and cost-effective solutions tailored to your market needs.
The contents of this page and any attachments are intended solely for the designated recipient(s) and may contain confidential and/or privileged information protected by law.
Any patented products are excluded from our offerings in regions where such patents are currently in force.
Duloxetine Pellets are primarily used in the treatment of major depressive disorder, generalized anxiety disorder, neuropathic pain, fibromyalgia, and chronic musculoskeletal pain.
Pellets provide uniform drug distribution, reduced risk of dose dumping, flexibility in dose adjustment, and improved patient compliance due to sustained/controlled release profiles.
Yes. They are designed for encapsulation, tableting, or sachet filling, making them versatile for various dosage forms.
We provide COA (Certificate of Analysis), MSDS (Material Safety Data Sheet), Stability Data, and necessary regulatory support documents.